Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $910.96 billion, total revenue of $172.71 billion and a weighted average PE ratio of 50.35.
Market Cap
910.96B
Revenue
172.71B
Profits
18.09B
PE Ratio
50.35
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 255.13B | -0.93% | 2,098,569 | 46.34B |
| 2 | DHR | Danaher Corporation | 161.01B | -1.06% | 3,518,492 | 25.11B |
| 3 | NTRA | Natera, Inc. | 56.71B | -2.80% | 1,581,348 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 48.77B | -1.47% | 2,900,998 | 7.37B |
| 5 | IDXX | IDEXX Laboratories, Inc. | 44.15B | 2.41% | 709,088 | 4.55B |
| 6 | IQV | IQVIA Holdings Inc. | 43.93B | -1.53% | 1,037,603 | 16.98B |
| 7 | WAT | Waters Corporation | 42.93B | -1.62% | 902,298 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 39.64B | -2.01% | 2,489,441 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 32.51B | -1.02% | 263,948 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.94B | -1.74% | 800,026 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.79B | -2.19% | 679,544 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 21.28B | -4.39% | 1,975,411 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.26B | -1.61% | 297,570 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 17.03B | -1.34% | 1,336,608 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.33B | -1.99% | 674,686 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.13B | -2.83% | 667,914 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.54B | -0.09% | 1,995,603 | 2.10B |
| 18 | RDNT | RadNet, Inc. | 5.41B | -2.29% | 385,465 | 2.27B |
| 19 | GRAL | GRAIL, Inc. | 5.26B | -13.03% | 1,304,708 | 165.26M |
| 20 | SHC | Sotera Health Company | 5.11B | -1.00% | 1,855,399 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.63B | -4.49% | 605,635 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.83B | -6.10% | 1,940,957 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.47B | -2.86% | 2,063,233 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.31B | -4.02% | 1,497,639 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.14B | -3.48% | 2,308,887 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 1.90B | -9.37% | 644,155 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.67B | -1.76% | 3,304,766 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.26B | -4.39% | 902,987 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.14B | -4.97% | 11,966,101 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 976.36M | -5.44% | 380,930 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 545.08M | -6.94% | 443,163 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 380.69M | -8.51% | 1,421,912 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 249.64M | -4.73% | 79,571 | 102.94M |
| 34 | XGN | Exagen Inc. | 187.02M | -9.81% | 965,808 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 136.05M | -17.31% | 24,908 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 98.50M | -1.31% | 181,499 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 89.11M | -2.75% | 336,904 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 38.27M | -5.17% | 95,130 | 27.20M |
| 39 | MDXH | MDxHealth SA | 19.71M | -65.77% | 17,033,619 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.11M | -7.06% | 14,348 | - |
| 41 | ADVB | Advanced Biomed Inc. | 6.58M | -18.44% | 28,209 | 127.64K |
| 42 | XWEL | XWELL, Inc. | 6.30M | -1.81% | 28,993 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.79M | -5.81% | 100,102 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.31M | -10.97% | 46,373 | 466.30K |